Drug Shortage Report for TEVA-TOPOTECAN
Report ID | 160980 |
Drug Identification Number | 02441071 |
Brand name | TEVA-TOPOTECAN |
Common or Proper name | TOPOTECAN PINF 4MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TOPOTECAN |
Strength(s) | 4MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 |
ATC code | L01CE |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-18 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-05-19 |
Company comments | Item is on Suspended Supply for now. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-05-19 | French | Compare |
v1 | 2022-05-19 | English | Compare |
Showing 1 to 2 of 2